Literature DB >> 17413763

Venous and arterial thrombosis in patients with HIV infection.

Evy Micieli1, Francesco Dentali, Massimo Giola, Paolo Grossi, Achille Venco, Walter Ageno.   

Abstract

Thromboembolic complications in HIV-infected patients have been reported. To our knowledge, no case-control studies have compared the prevalence of thromboembolic events between HIV-positive and HIV-negative individuals. One hundred and sixty-nine HIV-infected patients and 180 randomly selected blood donors were enrolled. Selected patients completed a specific questionnaire and were subsequently interviewed. Information was collected on family and personal history of cardiovascular disorders and the presence of personal risk factors for venous and arterial thrombosis. All reported events were adjudicated only if adequate documentation of objective tests was available. Mean age and sex were similar in the two groups. A vascular event was documented in six HIV-infected patients (3.55%) and in none of the controls (P=0.0108). Family history of cardiovascular disorders, cigarette smoking and hypertriglyceridemia were more prevalent in HIV patients than in controls. In multivariate analysis, neither family traditional cardiovascular risk factors nor HIV infection were independently associated with the presence of thromboembolic events. The results confirm the hypothesis that HIV-positive patients have an increased risk of thromboembolic disorders. Whether this increased risk has been provoked by HIV infection itself or by other associated risk factors for cardiovascular events, such as cigarette smoking and hypertriglyceridemia, remain to be clarified.

Entities:  

Mesh:

Year:  2007        PMID: 17413763     DOI: 10.1097/MBC.0b013e32808738a3

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  6 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

Review 2.  Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era.

Authors:  Nancy F Crum-Cianflone; Jhamillia Weekes; Mary Bavaro
Journal:  AIDS Patient Care STDS       Date:  2008-10       Impact factor: 5.078

Review 3.  Coagulation Parameters in Human Immunodeficiency Virus Infected Patients: A Systematic Review and Meta-Analysis.

Authors:  Solomon Getawa; Tiruneh Adane
Journal:  AIDS Res Treat       Date:  2022-04-21

4.  A comparison of perioperative safety for breast augmentation in cis- vs. trans patients.

Authors:  Kyle S Gabrick; Fouad Chouiari; Kitae E Park; Omar Allam; Mohammed Ali Mozaffari; John A Persing; Michael Alperovich
Journal:  Ann Transl Med       Date:  2021-04

5.  von Willebrand Factor is elevated in HIV patients with a history of thrombosis.

Authors:  Lennert W J van den Dries; Rob A Gruters; Sascha B C Hövels-van der Borden; Marieke J H A Kruip; Moniek P M de Maat; Eric C M van Gorp; Marchina E van der Ende
Journal:  Front Microbiol       Date:  2015-03-11       Impact factor: 5.640

6.  Coronavirus Disease of 2019 in Patients With Well-Controlled Human Immunodeficiency Virus on Antiretroviral Therapy.

Authors:  Rahul Shekhar; Ashley Barton; Abu Baker Sheikh; Shubhra Upadhyay; Natalie M Salas
Journal:  J Acquir Immune Defic Syndr       Date:  2020-09-01       Impact factor: 3.731

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.